Arabic Arabic English English French French German German
dark

OCTAVE study reveals vaccine responses in patients with impaired immune systems

The OCTAVE study—a multi-center, UK-wide trial, led by the University of Glasgow and co-ordinated by the University of Birmingham’s Cancer Research UK Clinical Trials Unit—is evaluating the immune responses following COVID-19 vaccination in patients with immune-mediated inflammatory diseases such as cancer, inflammatory arthritis, diseases of the kidney or liver, or patients who are having a stem cell transplant. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Antidote Health Raises $12M to Build First Virtual HMO in the U.S.

Next Post

UPS Launches First COVID-19 Vaccine Drone Deliveries at Atrium Health Wake Forest

Related Posts
Total
0
Share